178 related articles for article (PubMed ID: 32222382)
1. Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI.
Landon-Cardinal O; Koumako C; Hardouin G; Granger B; Reyngoudt H; Boisserie JM; Rigolet A; Hervier B; Champtiaux N; Guillaume-Jugnot P; Vautier M; Benveniste O; Carlier PG; Allenbach Y
Semin Arthritis Rheum; 2020 Dec; 50(6):1437-1440. PubMed ID: 32222382
[TBL] [Abstract][Full Text] [Related]
2. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L
Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398
[TBL] [Abstract][Full Text] [Related]
3. Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies.
Fionda L; Lauletta A; Leonardi L; Perez JA; Morino S; Merlonghi G; Alfieri G; Costanzo R; Tufano L; Vanoli F; Rossini E; Vigo EG; Tartaglione T; Salvetti M; Antonini G; Diaz-Manera J; Garibaldi M
J Neurol; 2023 Feb; 270(2):960-974. PubMed ID: 36329184
[TBL] [Abstract][Full Text] [Related]
4. Radiographic patterns of muscle involvement in the idiopathic inflammatory myopathies.
Day JA; Bajic N; Gentili S; Patel S; Limaye V
Muscle Nerve; 2019 Nov; 60(5):549-557. PubMed ID: 31397909
[TBL] [Abstract][Full Text] [Related]
5. Immune-Mediated Necrotizing Myopathy.
Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
[TBL] [Abstract][Full Text] [Related]
6. Muscle Magnetic Resonance Imaging for the Differentiation of Multiple Acyl-CoA Dehydrogenase Deficiency and Immune-mediated Necrotizing Myopathy.
Zhao YW; Liu XJ; Zhang W; Wang ZX; Yuan Y
Chin Med J (Engl); 2018 Jan; 131(2):144-150. PubMed ID: 29336361
[TBL] [Abstract][Full Text] [Related]
7. Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy.
Oda F; Uzawa A; Ozawa Y; Yasuda M; Kuwabara S
J Neuroimmunol; 2022 Apr; 365():577833. PubMed ID: 35219938
[TBL] [Abstract][Full Text] [Related]
8. [Retrospective study on clinical manifestation, thigh MRI and electrophysiology characteristics of immune-mediated necrotizing myopathy].
Qiao LY; Shi Q; Lin MY; Liu J; Chen ZJ; Pu C
Zhonghua Nei Ke Za Zhi; 2022 Oct; 61(10):1144-1151. PubMed ID: 36207969
[No Abstract] [Full Text] [Related]
9. [Immune-Mediated Necrotizing Myopathy: IMNM].
Tomimitsu H
Brain Nerve; 2021 Feb; 73(2):127-136. PubMed ID: 33561827
[TBL] [Abstract][Full Text] [Related]
10. Immune Mediated Necrotizing Myopathy: a Cause of Isolated Myopathy of Neck Extensor Muscle.
Sehgal R; Medina-Flores R; Yachoui R; Kenney CV
Clin Med Res; 2016 Dec; 14(3-4):145-150. PubMed ID: 27573534
[TBL] [Abstract][Full Text] [Related]
11. Autophagy markers LC3 and p62 accumulate in immune-mediated necrotizing myopathy.
Girolamo F; Lia A; Annese T; Giannini M; Amati A; D'Abbicco D; Tampoia M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Trojano M
Muscle Nerve; 2019 Sep; 60(3):315-327. PubMed ID: 31172530
[TBL] [Abstract][Full Text] [Related]
12. Clinical and histological features of immune-mediated necrotising myopathy: A multi-centre South Australian cohort study.
Day J; Otto S; Cash K; Limaye V
Neuromuscul Disord; 2020 Mar; 30(3):186-199. PubMed ID: 32229165
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological Features of Myositis and Necrotizing Myopathy: How to Distinguish between Myositis and Muscular Dystrophy on Muscle Pathology].
Saito Y; Nishino I
Brain Nerve; 2021 Feb; 73(2):147-159. PubMed ID: 33561829
[TBL] [Abstract][Full Text] [Related]
14. Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts.
Ma X; Bu BT
Front Immunol; 2022; 13():1019972. PubMed ID: 36311711
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of cardiac involvement in immune-mediated necrotizing myopathy.
Liu M; Lin Y; Qiao L; Chen J; Shi Q
Front Immunol; 2023; 14():1094611. PubMed ID: 36926343
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Expression of High Mobility Group Box Protein 1 in the Idiopathic Inflammatory Myopathies.
Day J; Otto S; Cash K; Eldi P; Hissaria P; Proudman S; Limaye V; Hayball JD
Front Cell Dev Biol; 2020; 8():226. PubMed ID: 32363191
[TBL] [Abstract][Full Text] [Related]
17. Thigh MRI in antisynthetase syndrome, and comparisons with dermatomyositis and immune-mediated necrotizing myopathy.
Zhang W; Zheng Y; Wang Y; Xiong H; Que C; Zhang X; Zhu Y; Zhao Y; Yu M; Meng L; Lv H; Zhang W; Hao H; Xiao J; Yuan Y; Wang Z
Rheumatology (Oxford); 2022 Dec; 62(1):310-320. PubMed ID: 35512205
[TBL] [Abstract][Full Text] [Related]
18. Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy.
Lim J; Rietveld A; De Bleecker JL; Badrising UA; Saris CGJ; van der Kooi AJ; de Visser M
Neurol Neuroimmunol Neuroinflamm; 2019 Jan; 6(1):e513. PubMed ID: 30345336
[TBL] [Abstract][Full Text] [Related]
19. Global versus individual muscle segmentation to assess quantitative MRI-based fat fraction changes in neuromuscular diseases.
Reyngoudt H; Marty B; Boisserie JM; Le Louër J; Koumako C; Baudin PY; Wong B; Stojkovic T; Béhin A; Gidaro T; Allenbach Y; Benveniste O; Servais L; Carlier PG
Eur Radiol; 2021 Jun; 31(6):4264-4276. PubMed ID: 33219846
[TBL] [Abstract][Full Text] [Related]
20. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
Basharat P; Christopher-Stine L
Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]